GTBPVSOPAD• 6 Months (Normalized)
GTBP vs OPAD (GT Biopharma Inc. vs Offerpad Solutions Inc.)
Showing Closing Date Range from Apr 2 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.88
+1427.78%
GT Biopharma Inc.
Normalized Baseline0.00%
OPAD Performance $3.41
+%
Offerpad Solutions Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1427.78 pts
GTBP outperforming by 1427.78 percentage points
GTBPOPAD
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP OPAD
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | GTBP Price | GTBP Gain (%) | OPAD Price | OPAD Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $6.88 | +1427.78% | $- | - | |
| Sep 28, 2026 | $6.80 | +1411.11% | $- | - | |
| Sep 25, 2026 | $6.89 | +1431.11% | $- | - | |
| Sep 24, 2026 | $6.83 | +1417.78% | $- | - | |
| Sep 23, 2026 | $7.10 | +1477.78% | $3.41 | +392.77% | +1085.01% |
| Sep 21, 2026 | $7.18 | +1495.56% | $3.41 | +392.77% | +1102.79% |
| Sep 18, 2026 | $7.16 | +1491.11% | $3.56 | +414.45% | +1076.66% |
| Sep 17, 2026 | $7.49 | +1564.44% | $3.47 | +401.45% | +1162.99% |
| Sep 16, 2026 | $7.81 | +1635.56% | $3.48 | +402.89% | +1232.67% |
| Sep 15, 2026 | $9.00 | +1900.00% | $3.57 | +415.90% | +1484.10% |
| Sep 14, 2026 | $11.63 | +2484.44% | $3.63 | +424.57% | +2059.87% |
| Sep 11, 2026 | $8.61 | +1813.33% | $3.80 | +449.13% | +1364.20% |
| Sep 10, 2026 | $6.18 | +1273.33% | $3.77 | +444.80% | +828.53% |
| Sep 09, 2026 | $5.98 | +1228.89% | $3.85 | +456.36% | +772.53% |
| Sep 08, 2026 | $- | $4.00 | +478.03% | - |
Page 1 of 9